4.8 Article

Osmoprotectant Coated Thermostable Gold Nanoparticles Efficiently Restrict Temperature-Induced Amyloid Aggregation of Insulin

Journal

JOURNAL OF PHYSICAL CHEMISTRY LETTERS
Volume 12, Issue 7, Pages 1803-1813

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/acs.jpclett.0c03492

Keywords

-

Funding

  1. DST-PURSE II
  2. UGC RN
  3. UGC DRS SAPI
  4. UPE II-JNU [377]
  5. UGC Start-up Grant
  6. SERB-DST EMR [EMR/2017/005000]
  7. CSIR
  8. UGC

Ask authors/readers for more resources

The study synthesized gold nanoparticles coated with osmolytes, which were found to inhibit temperature-induced amyloid aggregation of insulin. The nanoparticles interacted directly with insulin, protecting it from aggregation-prone domains under extreme conditions, suggesting potential for antiamyloid nanoformulations.
Naturally occurring osmoprotectants are known to prevent aggregation of proteins under various stress factors including extreme pH and elevated temperature conditions. Here, we synthesized gold nanoparticles coated with selected osmolytes (proline, hydroxyproline, and glycine) and examined their effect on temperature-induced amyloid-formation of insulin hormone. These uniform, thermostable, and hemocompatible gold nanoparticles were capable of inhibiting both spontaneous and seed-induced amyloid aggregation of insulin. Both quenching and docking experiments suggest a direct interaction between the osmoprotectant-coated nanoparticles and aggregation-prone hydrophobic stretches of insulin. Circular-dichroism results confirmed the retention of insulin's native structure in the presence of these nanoparticles. Unlike the indirect solvent-mediated effect of free osmolytes, the inhibition effect of osmolyte-coated gold nanoparticles was observed to be mediated through their direct interaction with insulin. The results signify the protection of the exposed aggregation-prone domains of insulin from temperature-induced self-assembly through osmoprotectant-coated nanoparticles, and such effect may inspire the development of osmolyte-based antiamyloid nanoformulations.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available